Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Rang in aandelen
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Aandeelprijs
$8.03
Marktkapitalisatie
$6.31B
Verandering (1 dag)
1.07%
Verandering (1 jaar)
-8.04%
Land
CN
Handel Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Categorie
Healthcare
Dividendgeschiedenis van Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Shenzhen New Industries Biomedical Engineering Co., Ltd. (aandelsymbool: 300832) heeft in totaal 7 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $6.12
Dividendrendement (TTM): 0.0224
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $6.12
Dividendrendement (TTM): 0.0224
Dividendbetalingen voor Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) van 2020 tot 2026
Jaarlijkse dividendbetalingen
| Jaar | Dividend (aangepast voor aandelensplitsingen) | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | 14.00% |
| 2021 | $0.5263 | -33.34% |
| 2020 | $0.7895 | 0.00% |
Lijst van alle dividendbetalingen
| Jaar | Dividend | Wijzigen |
|---|---|---|
| 2026 (TTM) | $1.20 | -7.69% |
| 2025 | $1.30 | 30.00% |
| 2024 | $1.00 | 42.86% |
| 2023 | $0.7 | 16.67% |
| 2022 | $0.6 | -40.00% |
| 2021 | $1.00 | -33.33% |
| 2020 | $1.50 | 0.00% |
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal dividendbetalingen | Land |
|---|---|---|
| 176.00% |
US
|
|
| 181.00% |
IE
|
|
| 87.00% |
US
|
|
| 0.00% |
US
|
|
| 8.00% |
DE
|
